Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06555640 |
| Consolidated Lead Sponsor | Zhejiang Doer Biologics Co |
| Therapeutic Condition Cohort | Cardiovascular and Thrombosis |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 79 participants (ACTUAL) |
| Registered Start Date | 2024-08-01 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Peking University First Hospital | Beijing, China | Open Hospital Dossier -> |
| The First Hospital of Jilin University | Changchun, China | Open Hospital Dossier -> |
| The Second Hospital of Jilin University | Changchun, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.